Maria Ines Mitrani, Chief Science Officer at Organicell Regenerative Medicine, Inc. (BPSR), sold 195,000 shares at $0.27 ($54K) on 2021-05-07, disclosed to the SEC on 2021-05-07.
Open-market sale of $54k BPSR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.29 | 25,000 | $7K | 13.5% |
| 2 | $0.30 | 50,000 | $15K | 27.9% |
| 3 | $0.26 | 40,000 | $10K | 19.3% |
| 4 | $0.26 | 40,000 | $10K | 19.3% |
| 5 | $0.27 | 40,000 | $11K | 20.1% |
| Total | $0.28 avg | 195,000 |
| $54K |
| 100% |
| Filing → |
| BPSR | SELL | 2021-06-11 | $31K | — | Filing → |
| BPSR | SELL | 2021-06-08 | $34K | — | Filing → |
| BPSR | SELL | 2021-06-03 | $24K | — | Filing → |